ArticlePloS one2025

The impact of the centralized volume-based procurement policy on Chinese pharmaceutical manufacturing firms' R&D investment: A difference-in-differences approach.

Fangjun Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.